654
Views
1
CrossRef citations to date
0
Altmetric
Research Paper

rAAV9-UPII-TK-EGFP can precisely transduce a suicide gene and inhibit the growth of bladder tumors

ORCID Icon, ORCID Icon, , , , , & ORCID Icon show all
Pages 1171-1178 | Received 09 Nov 2019, Accepted 24 Oct 2020, Published online: 20 Nov 2020

References

  • Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108. doi:10.3322/caac.21262. PMID:25651787.
  • Liu X, Jiang J, Yu C, Wang Y, Sun Y, Tang J, Chen T, Bi Y, Liu Y, Zhang ZJ. Secular trends in incidence and mortality of bladder cancer in China, 1990–2017: A joinpoint and age-period-cohort analysis. Cancer Epidemiol. 2019;61:95–103. doi:10.1016/j.canep.2019.05.011. PMID:31176961.
  • Robertson AG, Kim J, Al-Ahmadie H, Bellmunt J, Guo G, Cherniack AD, Hinoue T, Laird PW, Hoadley KA, Akbani R, et al. Comprehensive molecular characterization of muscle-invasive bladder cancer. Cell. 2017;171:540–56.e25. doi:10.1016/j.cell.2017.09.007. PMID:28988769.
  • Babjuk M, Böhle A, Burger M, Capoun O, Cohen D, Compérat EM, Hernández V, Kaasinen E, Palou J, Rouprêt M, et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016. Eur Urol. 2017;71:447–461. doi:10.1016/j.eururo.2016.05.041. PMID:27324428.
  • Chang SS, Bochner BH, Chou R, Dreicer R, Kamat AM, Lerner SP, Lotan Y, Meeks JJ, Michalski JM, Morgan TM, et al. Treatment of non-metastatic muscle-invasive bladder cancer: AUA/ASCO/ASTRO/SUO guideline. J Urol. 2017;198:552–559. doi:10.1016/j.juro.2017.04.086. PMID:28456635.
  • Witjes JA, Compérat E, Cowan NC, De Santis M, Gakis G, Lebret T, Ribal MJ, Van der Heijden AG, Sherif A. European Association of Urology. EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines. Eur Urol. 2014;65:778–792. doi:10.1016/j.eururo.2013.11.046. PMID:24373477.
  • Luqmani YA. Mechanisms of drug resistance in cancer chemotherapy. Med Princ Pract. 2005;14(Suppl 1):35–48. doi:10.1159/000086183. PMID:16103712.
  • Cross D, Burmester JK. Gene therapy for cancer treatment: past, present and future. Clin Med Res. 2006;4:218–227. doi:10.3121/cmr.4.3.218. PMID:16988102.
  • He XD, Wang ZP, Wei HY, Zhou Q, Wang DG, Tian JQ, Fu SJ, Rodriguez R. Construction of urothelium-specific recombinant adenovirus and its inhibition in bladder cancer cell. Urol Int. 2009;82:209–213. doi:10.1159/000200802. PMID:19322012.
  • Wang D, Wang Z, Tian J, He X, Chowdhury WH, Zhang X, Li S, Rodriguez R. Prostate stem cell antigen enhancer and uroplakin II promoter based bladder cancer targeted tissue-specific vector. Urol Oncol. 2010;28:164–169. doi:10.1016/j.urolonc.2008.02.002. PMID:18440837.
  • Wang DG, Zhao MJ, Liu YQ, Liu XW, Niu HT, Song YF, Tian YX. Fiber-modified adenovirus-mediated suicide gene therapy can efficiently eliminate bladder cancer cells in vitro and in vivo. Oncotarget. 2016;7:71710–71717. doi:10.18632/oncotarget.12324. PMID:27687590.
  • Ai J, Wang D, Wei Q, Li H, Gao G. Adeno-associated virus serotype vectors efficiently transduce normal prostate tissue and prostate cancer cells. Eur Urol. 2016;69:179–181. doi:10.1016/j.eururo.2015.10.019. PMID:26526960.
  • Cataldi MP, McCarty DM. Differential effects of DNA double-strand break repair pathways on single-strand and self-complementary adeno-associated virus vector genomes. J Virol. 2010;84:8673–8682. doi:10.1128/JVI.00641-10. PMID:20538857.
  • Wyndaele J, Riedl C, Taneja R, Lovász S, Ueda T, Cervigni M. GAG replenishment therapy for bladder pain syndrome/interstitial cystitis. Neurourol Urodyn. 2019;38:535–544. doi:10.1002/nau.23900. PMID:30592544.
  • Pan JG, Zhou X, Luo R, Han RF. The adeno-associated virus-mediated HSV-TK/GCV suicide system: a potential strategy for the treatment of bladder carcinoma. Med Oncol. 2012;29:1938–1947. doi:10.1007/s12032-011-0091-x. PMID:22011935.
  • Leten C, Trekker J, Struys T, Dresselaers T, Gijsbers R, Vande Velde G, Lambrichts I, Van Der Linden A, Verfaillie CM, Himmelreich U. Assessment of bystander killing-mediated therapy of malignant brain tumors using a multimodal imaging approach. Stem Cell Res Ther. 2015;6:163. doi:10.1186/s13287-015-0157-3. PMID:26345383.
  • Zychlinsky Scharff A, Albert ML, Ingersoll MA. Urinary tract infection in a small animal model: transurethral catheterization of male and female mice. J Vis Exp. 2017. doi:10.3791/54432. PMID:29286380.
  • Shen Y, Li Y, Ma X, Wan Q, Jiang Z, Liu Y, Zhang D, Liu X, Wu W. Connexin 43 SUMOylation improves gap junction functions between liver cancer stem cells and enhances their sensitivity to HSVtk/GCV. Int J Oncol. 2018;52:872–880. doi:10.3892/ijo.2018.4263. PMID:29393359.
  • Jiang H, Deng R, Yang X, Shang J, Lu S, Zhao Y, Song K, Liu X, Zhang Q, Chen Y, et al. Peptidomimetic inhibitors of APC-Asef interaction block colorectal cancer migration. Nat Chem Biol. 2017;13:994–1001. doi:10.1038/nchembio.2442. PMID:28759015.
  • Tang M, Luo Z, Wu Y, Zhuang J, Li K, Hu D, Rong H, Xian B, Ge J. BAM15 attenuates transportation-induced apoptosis in iPS-differentiated retinal tissue. Stem Cell Res Ther. 2019;10:64. doi:10.1186/s13287-019-1151-y. PMID:30795805.
  • Zhao D, Zhang M, Yuan H, Meng C, Zhang B, Wu H. Ginsenoside Rb1 protects against spinal cord ischemia-reperfusion injury in rats by downregulating the Bax/Bcl-2 ratio and caspase-3 and p-Ask-1 levels. Exp Mol Pathol. 2018;105:229–235. doi:10.1016/j.yexmp.2018.09.001. PMID:30184471.
  • Zhao MJ, Song YF, Niu HT, Tian YX, Yang XG, Xie K, Jing YH, Wang DG. Adenovirus-mediated downregulation of the ubiquitin ligase RNF8 sensitizes bladder cancer to radiotherapy. Oncotarget. 2016;7:8956–8967. doi:10.18632/oncotarget.6909. PMID:26788910.
  • Chen Y, Huang H, Yao C, Su F, Guan W, Yan S, Ni Z. Antitumor activity of combined endostatin and thymidine kinase gene therapy in C6 glioma models. Cancer Med. 2016;5:2477–2486. doi:10.1002/cam4.798. PMID:27366865.
  • Choi SS, Chi BH, Chang IH, Kim KD, Lee SR, Kim SU, Lee HJ. Human neural stem cells overexpressing a carboxylesterase inhibit bladder tumor growth. Mol Cancer Ther. 2016;15:1201–1207. doi:10.1158/1535-7163.MCT-15-0636. PMID:27009215.
  • Zhang Y, Wang J, Cheng H, Sun Y, Liu M, Wu Z, Pei R. Conditional control of suicide gene expression in tumor cells with theophylline-responsive ribozyme. Gene Ther. 2017;24:84–91. doi:10.1038/gt.2016.78. PMID:27874855.
  • Appaiahgari MB, Vrati S. Adenoviruses as gene/vaccine delivery vectors: promises and pitfalls. Expert Opin Biol Ther. 2015;15:337–351. doi:10.1517/14712598.2015.993374. PMID:25529044.
  • Irie A. Advances in gene therapy for bladder cancer. Curr Gene Ther. 2003;3:1–11. PMID:12553531.
  • Baruteau J, Waddington SN, Alexander IE, Gissen P. Gene therapy for monogenic liver diseases: clinical successes, current challenges and future prospects. J Inherit Metab Dis. 2017;40:497–517. doi:10.1007/s10545-017-0053-3. PMID:28567541.
  • Lin LF, Zhu G, Yoo JJ, Soker S, Sukhatme VP, Atala A. A system for the enhancement of adenovirus mediated gene transfer to uro-epithelium. J Urol. 2002;168:813–818. doi:10.1016/S0022-5347(05)64749-0. PMID:12131373.
  • Janssen D. ls clinical practice aligned with the latest scientific evidence on GAG therapy. Urologia. 2017;84:16–20. doi:10.5301/uj.5000259. PMID:28862729.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.